NORTHBROOK, IL, [March 10], 2025 – IDEX Corporation (NYSE: IEX) today announced that Jim Giannakouros will join the Company as Vice President of Investor Relations, effective March 10. In this role, he will provide strategic leadership to the Executive Leadership Team, strengthen relationships within the investment community, and enhance the company’s investor relations function. Mr. Giannakouros will report to Abhi Khandelwal, Senior Vice President and Chief Financial Officer.
Mr. Giannakouros brings more than 25 years of financial and industry experience through various buy side, sell side, and investor relations roles, including at Osprey Partners Investment Management as a Generalist and member of the Large-cap Value Equity team, a sell side equity research associate at Bear, Stearns & Co., CIBC World Markets, and Susquehanna International Group, and more recently as Managing Director and Senior Analyst at Oppenheimer & Co. During his tenure, Mr. Giannakouros’ coverage universe centered on the Industrials sector, and notably included IDEX. Over the last six years, his corporate roles have included Vice President of Investor Relations and FP&A at Carlisle Companies Inc. (NYSE: CSL), a large-cap industrial and leading supplier of innovative, energy-efficient building products and solutions, where he developed an award-winning IR function, and Senior Director of Investor Relations at Kenvue Inc. (NYSE: KVUE), the largest pure-play consumer health company globally.
“We are thrilled to have Jim join the IDEX team,” Mr. Khandelwal said. “His years of experience spanning multiple sectors, including industrials, and record of leveraging his extensive financial and capital markets experience will help us effectively communicate and develop relationships with new and existing investors. We are fortunate to have a professional of Jim’s caliber leading our investor relations efforts and look forward to the meaningful impact he will have.”
Mr. Giannakouros holds a BA degree in Statistics/Mathematics from Rutgers University and an MBA in Finance from the Stern School of Business at New York University. He is also a CFA® charterholder.
Forward-Looking Statements
This news release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, the Company’s first quarter 2025 and full year 2025 outlook including expected organic sales, expected earnings per share, and expected adjusted earnings per share and the assumptions underlying these expectations, anticipated future acquisition behavior, resource deployment and focus and organic and inorganic growth, returns on invested capital, anticipated trends in end markets, anticipated growth initiatives and the anticipated benefits of the Company’s recent or future acquisitions and are indicated by words or phrases such as “anticipates,” “estimates,” “plans,” “guidance,” “expects,” “projects,” “forecasts,” “should,” “could,” “will,” “management believes,” “the Company believes,” “the Company intends” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this news release. The risks and uncertainties include, but are not limited to, the following: levels of industrial activity and economic conditions in the U.S. and other countries around the world, including uncertainties in the financial markets; pricing pressures, including inflation and rising interest rates, and other competitive factors and levels of capital spending in certain industries; the impact of severe weather events, natural disasters and public health threats; economic and political consequences resulting from terrorist attacks and wars; the Company’s ability to make acquisitions and to integrate and operate acquired businesses on a profitable basis; cybersecurity incidents; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in countries in which the Company operates; developments with respect to trade policy and existing, new or increased tariffs or other similar measures; interest rates; capacity utilization and the effect this has on costs; labor markets; supply chain conditions; market conditions and material costs; risks related to environmental, social and corporate governance issues, including those related to climate change and sustainability; and developments with respect to contingencies, such as litigation and environmental matters. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included in the Company’s most recent annual report on Form 10-K and the Company’s subsequent quarterly reports filed with the Securities and Exchange Commission (“SEC”) and the other risks discussed in the Company’s filings with the SEC. The forward-looking statements included here are only made as of the date of this news release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.
About IDEX
IDEX Corporation (NYSE: IEX) designs and builds engineered products and mission-critical components that make everyday life better. IDEX precision components help craft the microchip powering your electronics, treat water so it is safe to drink, and protect communities and the environment from sewer overflows. Our optics enable global broadband satellite communications, and our pumps move challenging fluids that range from hot, to viscous, to caustic. IDEX components assist healthcare professionals in saving lives as part of many leading diagnostic machines, including DNA sequencers that help doctors personalize treatment. And our fire and rescue tools, including the industry-leading Hurst Jaws of Life®, are trusted by rescue workers around the world. These are just some of the thousands of products that help IDEX live its purpose – Trusted Solutions, Improving Lives™. Founded in 1988 with three small, entrepreneurial manufacturing companies, IDEX now includes more than 50 diverse businesses around the world. With about 9,000 employees and manufacturing operations in more than 20 countries, IDEX is a diversified, high-performing, global company with approximately $3.3 billion in annual sales. For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.
Investor Contact: jgiannakouros@idexcorp.com
Media Contact: mdspencer@idexcorp.com